Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
余語 覚文; 佐藤 克俊; 錦野 将元; 森 道昭; 手島 昭樹*; 沼崎 穂高*; 村上 昌雄*; 出水 祐介*; 赤城 卓*; 永山 伸一*; et al.
Applied Physics Letters, 94(18), p.181502_1 - 181502_3, 2009/05
被引用回数:109 パーセンタイル:94.78(Physics, Applied)We report the demonstrated irradiation effect of laser-accelerated protons on human cancer cells. (living) A549 cells are irradiated with quasi-monoenergetic proton bunches of 0.8-2.4 MeV with a single bunch duration of 15 ns. Irradiation with the proton dose of 20 Gy results in a distinct formation of -H2AX foci as an indicator of DNA double-strand breaks generated in the cancer cells. This is a pioneering result in view of future investigations on the radiobiological effects of laser-driven ion beams. Unique high-current and short-bunch features make laser-driven proton bunches an excitation source for time-resolved determination of radical yields.
村上 昌雄*; 出水 祐介*; 丹羽 康江*; 永山 伸一*; 前田 拓也*; 馬場 理師*; 宮脇 大輔*; 寺嶋 千貴*; 有村 健*; 美馬 正幸*; et al.
no journal, ,
The Hyogo Ion Beam Medical Center was established in May 2001, a leading project of the "Hyogo Cancer Strategy". The accelerator is a synchrotron that can accelerate proton and carbon ion beams at a maximum of 230 and 320 MeV/u, respectively, and the maximum ranges in water are 300 and 200 mm, respectively. Three irradiation rooms installed with 45-degree, horizontal/vertical, and horizontal fixed ports can be used for carbon ion radiation therapy, and 2 gantry rooms can be additionally used for proton beams. Particle beam radiation therapy had been performed in 2,639 patients as of the end of March 2009. The diseases treated were prostate cancer, head and neck tumors, liver cancer, lung cancer, and bone soft tissue tumors, in decreasing order of frequency, and these 5 major diseases accounted for 87% of the cases. As the current problems of particle beam radiation therapy, the effect of the differential use of proton and carbon ion beams is unclear, adverse events, such as skin disorders, may occur due to the limitation of the broad beam method, and the necessity to install large-scale devices is an obstacle to its dissemination. We are aiming at the development and clinical application of a laser-driven proton radiotherapy device in cooperation with the Japan Atomic Energy Agency.
前田 拓也; 余語 覚文; 出水 祐介*; 堀 利彦; 榊 泰直; 巴 悠介*; 近藤 公伯; 村上 昌雄*
no journal, ,
The Hyogo Ion Beam Medical Center (HIBMC) was established in May 2001, a leading project of the "Hyogo Cancer Strategy". As its major characteristic, both proton and carbon ion beams can be generated. The accelerator is a synchrotron that can accelerate proton and carbon ion beams at a maximum of 230 and 320 MeV/u, respectively. Three irradiation rooms installed with 45, horizontal/vertical, and horizontal fixed ports can be used for carbon ion radiation biological experiment and therapy. Moreover laser technology to accelerate particle beam therapy, by Japan Atomic Energy Agency (JAEA) advances development now aim to bring innovation to transform conventional treatment, and spread the particle beam therapy, taking advantage of the performance of particle beam therapy, proton therapy equipment laser driven activities are designed to achieve for clinical application to. We have so far, X-ray, proton, and carbon ion beam lines, the laser-driven proton ion beam, has been examined from the standpoint of comparative molecular cell biology of cancer cells to radiation effects. So far, considering the differences in the types of cytostatic effect and the effect of DNA cleavage and on the relevance of apoptosis studies in each lines irradiated cancer cells. In this presentation we reports on the difference of the irradiation effect in X-rays, the proton beam, and the carbon ion beam to the human cancer cell, and it applies on the focus to survival rate after the X-ray, synchrotron proton beam, the synchrotron carbon ion beam, and the laser driven proton is irradiated.
赤城 卓*; 山下 智弘*; 上本 賢司*; 榊 泰直; 出水 祐介*; 不和 信和*
no journal, ,
陽子線治療スキャニングシステムにおいては、線量分布を定量的に得る必要があり、一般的には有機シンチレータが用いられる。しかし、有機シンチレータは低エネルギー陽子から高エネルギー陽子までの線量リニアリティーが十分ではなくLETの評価が正確に行われない。そこで、無機材質のZnS(Ag)シンチレータを薄膜にすることで、この問題を解決し、精度の良いリアルタイム線量計の開発を兵庫県粒子線治療センターと、原子力機構と開発する。